The Traderszone Network

15 July, 2017 by The TZ Newswire Staff Comments Off on FEC Rejects Democrats’ Plan To Target Drudge, Breitbart

FEC Rejects Democrats’ Plan To Target Drudge, Breitbart

The efforts of top Federal Election Commission Democrat, Ellen Weintraub, to demand an inquisition into the potential coordination with Russians of conservative news outlets like Infowars, Breitbart and the Drudge Report, have been dashed as The Federal Election Commission (FEC) has declined her proposal, stating it “cannot support proposals that would burden the free speech rights of American citizens based on

read more

15 July, 2017 by The TZ Newswire Staff Comments Off on This multibillion dollar international movie niche is getting lots of love (and cash) from US firms

This multibillion dollar international movie niche is getting lots of love (and cash) from US firms

India’s multibillion-dollar entertainment industry is quickly gaining a global audience, and it’s not just because of the song and dance.

15 July, 2017 by The TZ Newswire Staff Comments Off on Spain’s Garbine Muguruza bests Venus Williams, taking Wimbledon’s crown

Spain’s Garbine Muguruza bests Venus Williams, taking Wimbledon’s crown

Garbine Muguruza of Spain won her second career Grand Slam title when she defeated Venus Williams at Wimbledon.

15 July, 2017 by The TZ Newswire Staff Comments Off on PBOC to get larger role in managing financial risks

PBOC to get larger role in managing financial risks

Chinese central bank to oversee systemic risk
Chinese leaders increasingly see financial instability at the greatest threat to their economy and nation.
President Xi Jinping said the PBOC will take a larger role in overseeing financial risks and creating more cohesive regulation.

15 July, 2017 by The TZ Newswire Staff Comments Off on Why You’re Smart to Buy Vertex Pharmaceuticals Stock

Why You’re Smart to Buy Vertex Pharmaceuticals Stock

You might look at Vertex Pharmaceuticals (NASDAQ: VRTX) stock and shake your head at its valuation. After soaring more than 70% so far in 2017, shares of the biotech now trade at a whopping 180 times trailing-12-month earnings. That’s the kind of price tag that would cause Warren Buffett’s mentor Benjamin Graham to spin in his grave.

Should this make you stay away from Vertex? I don’t think so. Here’s why you’re smart to buy the biotech stock even at its seemingly stratospheric valuation.

Image source: Getty Images.

read more

15 July, 2017 by The TZ Newswire Staff Comments Off on m22au’s journal

m22au’s journal

Long silver @ $5.00

15 July, 2017 by The TZ Newswire Staff Comments Off on NewsWatch: Here’s one reason why expensive stocks can continue to climb

NewsWatch: Here’s one reason why expensive stocks can continue to climb

By almost any fundamental measure, U.S.

read more